HEMATOLOGIC MALIGNANCIES
Clinical trials for HEMATOLOGIC MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGIC MALIGNANCIES trials appear
Sign up with your email to follow new studies for HEMATOLOGIC MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for elderly blood cancer patients: cord blood transplant study launches
Disease control Not yet recruitingThis study tests a new combination of chemotherapy drugs before a cord blood transplant in 44 patients aged 60-69 with blood cancers. The goal is to see if this approach lowers the risk of death from transplant complications within 180 days. Participants receive the transplant an…
Matched conditions: HEMATOLOGIC MALIGNANCIES
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 26, 2026 04:36 UTC
-
New CAR-T therapy aims to tackle tough blood cancers
Disease control Not yet recruitingThis early-stage study is testing a new type of CAR-T cell therapy for people with B-cell blood cancers (like certain leukemias and lymphomas) that have come back or stopped responding to standard treatments. The therapy uses donor immune cells that are specially designed to find…
Matched conditions: HEMATOLOGIC MALIGNANCIES
Phase: PHASE1 • Sponsor: YANRU WANG • Aim: Disease control
Last updated May 26, 2026 04:35 UTC
-
New hope for tough blood cancers: experimental drug enters human testing
Disease control Not yet recruitingThis early-stage study tests a new drug called BL-M24D1 in about 33 people whose multiple myeloma or other blood cancer has returned or stopped responding to standard treatments. The main goals are to check the drug's safety, find the best dose, and see if it helps shrink tumors.…
Matched conditions: HEMATOLOGIC MALIGNANCIES
Phase: PHASE1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
Could early antibiotic stop be safe for kids with cancer?
Disease control Not yet recruitingThis study looks at whether children with cancer who develop a fever and low white blood cells can safely stop antibiotics earlier than usual. About 136 children will be randomly assigned to stop antibiotics early or continue standard treatment. The goal is to see if early stoppi…
Matched conditions: HEMATOLOGIC MALIGNANCIES
Phase: PHASE4 • Sponsor: Hospital Universitari Vall d'Hebron Research Institute • Aim: Disease control
Last updated May 22, 2026 13:53 UTC